Skip to main content
SpringerLink
Log in

Female Pattern Hair Loss

  • Chapter
Hair Growth and Disorders

Abstract

• Decrease in hair density in the central (vertex, mid and frontal) scalp, bitemporal and parietal regions in women.

• Miniaturization of affected hairs.

• Two ages of onset: early (post-puberty to third decade) and late (age 40+ years).

• Signs of hyperandrogenism (hirsutism, irregular periods) or hyperandrogenemia occur in a subset of women with female pattern hair loss (FPHL) but most women with FPHL have neither.

• Many, but not all, affected women respond to antiandrogens or 5α-reductase inhibitors with increased hair growth indicating an androgen etiology in at least some cases of FPHL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Agarwal SK, Hughes CL, Hirsutism In Olsen EA (Ed) (2004) Disorders of Hair Growth: Diagnose and Treatment. McGraw-Hill, NY

    Google Scholar 

  2. Aram H (1979) Treatment of female androgenetic alopecia with cimetidine. Gastroenterology; 76: 504-508

    Google Scholar 

  3. Assiz R, Sanchez A, Knochenhauer ES, et al (2004) Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab; 89: 453–462

    Article  CAS  Google Scholar 

  4. Avram MR, Cole JP, Gandelman M, et al (2002) The potential role of minoxidil in the hair transplanting setting. J Dermatol Surg; 28: 10: 894-900

    Article  Google Scholar 

  5. Barman JM, Pecoraro V, Astore I (1969) Biological basis of the inception and evolution of baldness. J Gerontol; 24: 163-168

    PubMed  CAS  Google Scholar 

  6. Beek CH (1950) A study on extension and distribution of the human body-hair. Dermatologica; 101: 317-331

    Article  PubMed  CAS  Google Scholar 

  7. Bingham KD, Shaw DA (1973) The metabolism of testosterone by human male scalp hair. J Endocrinol; 57; 811-819

    Article  Google Scholar 

  8. Birch MP, Messenger JF, Messenger AG (2001) Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol; 144: 297-304

    Article  PubMed  CAS  Google Scholar 

  9. Birch MP, Lashen H, Agarwal S et al (2006) Female pattern hair loss, sebum excretion and the end-organ response to androgens. Br J Dermatol; 154: 85-89

    Article  PubMed  CAS  Google Scholar 

  10. Burke BM, Cunliffe WJ (1985) Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia [Letter]. Br J Dermatol; 112: 124-125

    Article  PubMed  CAS  Google Scholar 

  11. Camacho F (2001) Hissutismo: enfoque dclinico terapeutico. Act Terap Dermatol; 24: 190-206

    Google Scholar 

  12. Cameron DR, Braunstein GD (2004) Androgen replacement therapy in women. Fertil Steril; 82: 273-289

    Article  PubMed  CAS  Google Scholar 

  13. Carey AH, Waterworth D, Patel K, et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet; 3: 1873-1876

    Article  PubMed  CAS  Google Scholar 

  14. Carmina E, Lobo RA (2003) Treatment of hyperandrogenic alopecia in women. Fertil Steril; 79: 91-95

    Article  PubMed  Google Scholar 

  15. Cela E, Robertson C, Rush K, et al (2003) Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol; 149: 439-442

    Article  PubMed  CAS  Google Scholar 

  16. Chen WC, Thiboutot D, Zouboulis CC (2002) Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol; 119: 992-1007

    Article  PubMed  CAS  Google Scholar 

  17. Choi MH, Yoo YS, Chung BC (2001) Biochemical roles of testosterone and epitestosterone to 5α-reducatase as indicators of male-pattern baldness. J Invest Dermatol; 116: 57-61

    Article  PubMed  CAS  Google Scholar 

  18. Conrad F, Paus R (2004) Östrogene und der Haarfollikel. JDDG; 2: 412-423

    Article  PubMed  Google Scholar 

  19. Conrad F, Ohnemus U, Bodo E, et al (2004) Estrogens and human scalp hair growth – still more questions than answers. J Invest Dermatol; 122: 840-842

    Article  PubMed  CAS  Google Scholar 

  20. Corvol P, Michaud A, Menard J, et al (1975) Antiandrogenic effect of spironolactone: mechanism of action. Endocrinology; 97: 52-58

    Article  PubMed  CAS  Google Scholar 

  21. Courtois M, Loussouvn G, Hourseau C, et al (1995) Ageing and hair cycles. Br J Dermatol; 132: 86-93

    Article  PubMed  CAS  Google Scholar 

  22. Cusan L, Dupont A, Gomez JL, et al (1990) Treatment of hirsutism with the pure antiandrogen flutamide. J Am Acad Dermatol; 23: 462-469

    Article  PubMed  CAS  Google Scholar 

  23. Cusan L, Dupont A, Gomez JL, et al (1994) Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil Steril; 61: 281-287

    PubMed  CAS  Google Scholar 

  24. Dawber RPR, Sonnex T, Ralfs I. (1982) Oral anti-androgen treatment of common baldness in women. Br J Dermatol; 107 (suppl 22):20

    Google Scholar 

  25. Deloche C, de Lacharrière O, Misciali C, et al (2004) Histological features of peripilar signs associated with androgenetic alopecia. Arch Dermatol Res; 295(10): 422-428

    Article  PubMed  Google Scholar 

  26. DeVillez RL, Jacobs JP, Szpunar CA, et al (1994) Androgenetic alopecia in the female: treatment with 2% topical minoxidil solution. Arch Dermatol; 30: 303-307

    Article  Google Scholar 

  27. Drake LD, Hordinsky M, Fiedler V, et al (1999) The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol; 41: 550-554

    PubMed  CAS  Google Scholar 

  28. Ekoe JM, Burkhardt P, Ruedi B (1980) Treatment of hirsutism, acne and alopecia with cyproterone acetate. Dermatologica; 160: 398-404

    Article  PubMed  CAS  Google Scholar 

  29. Ferry JJ, Turner SW, Albert DG, et al (1996) Hemodynamic effects of minoxidil following intravenous infusion in untreated hypertensive patients. Clin Pharmacol Ther; 59: 166

    Article  Google Scholar 

  30. Fischer TW, Burmeister G, Schmidt HW et al (2004) Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br J Dermatol; 150: 341-345

    Article  PubMed  CAS  Google Scholar 

  31. Futterweit W, Dunaif A, Yeh H-C, et al (1988) The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol; 19: 831-836

    Article  PubMed  CAS  Google Scholar 

  32. Gan DCC, Sinclair RD (2005) Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc; 10: 184-189

    Article  PubMed  Google Scholar 

  33. Gassmueller J, Hoffmann R, Webster A (2007) A treatment of androgenetic alopecia using topical fulvestrant solution in males and post-meonopausal females. Poster presentation at European Hair Research Society meeting, London, Great Britain, June 2007

    Google Scholar 

  34. Gomez JL, Dupont A, Cusan L, et al (1992) Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients. Am J Med; 92: 465-470

    Article  PubMed  CAS  Google Scholar 

  35. Goss PE, Ingle JN, Martino S, et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med; 349: 1793-802

    Article  PubMed  CAS  Google Scholar 

  36. Guerrera M, Ciulla MP (1986) A quantitative evaluation of hair loss: the phototrichogram. J Appl Cosmetol; 4: 61-66

    Google Scholar 

  37. Guerrera M, Rebora A (1996) Anagen hairs may fail to replace telogen hairs in early androgenic female alopecia. Dermatology; 192: 28-31

    Article  Google Scholar 

  38. Hamilton JB (1942) Male hormone stimulation is prerequisite to an incite in common baldness. Am J Anat; 71: 451-452

    Article  Google Scholar 

  39. Hamilton JB (1951) Patterned loss of hair in man: types and incidence. Ann NY Acad Sci; 53: 708-728

    Article  PubMed  CAS  Google Scholar 

  40. Hammerstein J, Meckies J, Leo-Rossberg I, et al (1975) Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism or virilism. J Steroid Biochem; 6: 827-836

    Article  PubMed  CAS  Google Scholar 

  41. Hoffmann R, Rot A, Niiyama S, et al (2001) Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Invest Dermatol; 117(6): 1342-1348

    Article  PubMed  CAS  Google Scholar 

  42. Iorizzo M, Vincenzi C, Voudouris S, et al (2006) Finasteride treatment of female pattern hair loss. Arch Dermatol; 142: 298-302

    Article  PubMed  CAS  Google Scholar 

  43. Jackson D, Church RE, Ebling FJ (1972) Hair diameter in female baldness. Br J Dermatol; 87: 361-367

    Article  PubMed  CAS  Google Scholar 

  44. Jacobs JP, Szpunar CA, Warner ML (1993) Use of topical minoxidil therapy for androgenetic alopecia in women. Int J Dermatol; 32: 758-762

    Article  PubMed  CAS  Google Scholar 

  45. Kaufman KD, Olsen EA, Whiting D, et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol; 39:578-589

    Article  PubMed  CAS  Google Scholar 

  46. Kossard S (1994) Postmenopausal frontal fibrosing alopecia. Arch Dermatol; 130: 770-774

    Article  PubMed  CAS  Google Scholar 

  47. Labrie F, Luu-The V, Labrie C, et al (2000) Intracrinology and the skin. Hormone Res 2000; 54: 213-229

    Article  Google Scholar 

  48. Lobo RA, Shoupe D, Serafini P, et al (1985) The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril; 43: 200-205

    PubMed  CAS  Google Scholar 

  49. Lucky AW, Piacquadio DJ, Ditre CM, et al (2004) A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol; 50: 541-553

    Article  PubMed  Google Scholar 

  50. Ludwig E (1964) Die androgenetische alopecie bei der Frau. Arch Klin Exp Dermatol; 219: 558

    Article  PubMed  CAS  Google Scholar 

  51. Ludwig E (1977) Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol; 97: 247-254

    Article  PubMed  CAS  Google Scholar 

  52. Maguire HC Jr, Kligman AM (1963) Common baldness in women. Geriatrics; 18: 329-334

    Google Scholar 

  53. Mansouri P, Mortazavi M, Eslami M et al (2005) Androgenetic alopecia and coronary artery disease in women. Dermatol Online J; 11(3): 2

    PubMed  Google Scholar 

  54. Messenger AG, Rundegren J (2004) Minoxidil: mechanisms of action on hair growth. Br J Dermatol; 150: 186-194

    Article  PubMed  CAS  Google Scholar 

  55. Mortimer CH, Rushton H, James KC (1984) Effective medical treatment for common baldness in women. Clin Exp Dermatol; 9: 342-350

    Article  PubMed  CAS  Google Scholar 

  56. Niiyama S, Happle R, Hoffmann R (2001) Influence of estrogens on the androgen metabolism in different subunits of human hair follicles. Eur J Dermatol; 11: 195-198

    PubMed  CAS  Google Scholar 

  57. Norwood OT (2001) Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg; 27: 53-54

    Article  PubMed  CAS  Google Scholar 

  58. Oh H-S, Smart RC (1996) An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci; 93: 12525-12530

    Article  PubMed  CAS  Google Scholar 

  59. Olsen EA (1994) Androgenetic alopecia. In: Olsen EA (Ed) (1994) Disorders of Hair Growth: Diagnosis and Treatment. New York: McGraw-Hill; p. 257-283

    Google Scholar 

  60. Olsen EA (1994) Clinical tools for assessing hair loss. In Olsen EA (Ed) (1994) Disorders of Hair Growth: Diagnosis and Treatment. New York: McGraw-Hill; p. 59-69

    Google Scholar 

  61. Olsen EA (1999) The midline part: an important physical clue to the clinical diagnosis of androgenetic alopecia in women. J Am Acad Dermatol; 40: 106-109

    Article  PubMed  CAS  Google Scholar 

  62. Olsen EA (2001) Female pattern hair loss. J Am Acad Dermatol; 45: S70-S80

    Article  PubMed  CAS  Google Scholar 

  63. Olsen EA (2003) Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss. J Am Acad Dermatol; 48: 253-262

    Article  PubMed  Google Scholar 

  64. Olsen EA (2004) Pattern hair loss in men and women, in Olsen EA (Ed) Hair Disorders: Diagnosis and Treatment. McGraw-Hill, NY

    Google Scholar 

  65. Olsen EA (2005) Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective. J Investig Dermatol Symp Proc; 10(3): 217-221

    Article  PubMed  Google Scholar 

  66. Olsen EA, Weiner MS (1987) Topical minoxidil in male pattern baldness: effect of discontinuation of treatment . J Am Acad Dermatol; 17: 97-101

    Article  PubMed  CAS  Google Scholar 

  67. Olsen EA, Weiner MS, DeLong ER, et al (1985) Topical minoxidil in early male pattern baldness. J Am Acad Dermatol; 13: 185-192

    Article  PubMed  CAS  Google Scholar 

  68. Olsen EA, Bergfeld W, Cotsarelis G, et al (2003) Summary of NAHRS-sponsored workshop on cicatricial alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol; 48:103-110

    Article  PubMed  Google Scholar 

  69. Olsen EA, Messenger AG, Shapiro J, et al (2005) Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol; 52: 301-311

    Article  PubMed  Google Scholar 

  70. Olsen EA, Hordinsky M, Whiting D, et al (2006) The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol; 55: 1014-1023

    Article  PubMed  Google Scholar 

  71. Olsen EA, Whiting D, Bergfeld W, et al (2007) A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam vs placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol; 57(5): 767-774

    Article  PubMed  Google Scholar 

  72. Olszewska M, Rudnicka L (2005) Effective treatment of female androgenic alopecia with dutasteride. J Drugs Dermatol; 4: 637-640

    PubMed  Google Scholar 

  73. Orfanos CE, Vogels L (1980) Lokaltherapie der Alopecia Androgenetica mit 17a –Östradiol. Dermatologica; 161: 124-132

    Article  PubMed  CAS  Google Scholar 

  74. Orme S, Cullen DR, Messenger AG (1999) Diffuse female hair loss: are androgens necessary? Br J Dermatol; 141: 521-523

    Article  PubMed  CAS  Google Scholar 

  75. Park JH, Yoon JB, Sim WY, et al (2001) The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol; 145: 95-99

    Article  Google Scholar 

  76. Peereboom-Wynia JD, van der Willigen AH, van Joost T, et al (1989) The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females. Acta Dermatol Venereol; 69: 395-398

    CAS  Google Scholar 

  77. Price VH, Roberts JL, Hordinsky M, et al (2000) Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol; 43 (5 Pt 1): 768-76

    Article  PubMed  CAS  Google Scholar 

  78. Puerto AM, Mallol J (1990) Regional scalp differences of the androgenetic metabolic pattern in subjects affected by male pattern baldness. Rev Esp Fisiol; 46: 289-286

    PubMed  CAS  Google Scholar 

  79. Riggs BL, Hartmann LC (2003) Seletive estrogen-receptor modulators – mechanism of action and application to clinical practice. N Engl J Med; 348: 618-629

    Article  PubMed  CAS  Google Scholar 

  80. Roberts JL, Fielder V, Imperato-McGinley J, et al (1999) Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol; 41:555-563

    PubMed  CAS  Google Scholar 

  81. Rushton DH, Ramsay ID (1992) The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women. Clin Endocrinol; 36: 421-424

    Article  CAS  Google Scholar 

  82. Rushton DH, Futterweit W, Kingsley DH, et al (1991) Quantitative assessment of spironolactone treatment of women with diffuse androgen-dependent alopecia. J Soc Cosmet Chem; 42: 317-325

    Google Scholar 

  83. Sawaya ME, Price VH (1997) Different levels of 5α-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol; 109: 296-300

    Article  PubMed  CAS  Google Scholar 

  84. Schmidt HB, Lindmaier A, Trenz A, et al (1991) Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest; 31: 235-239

    Article  PubMed  CAS  Google Scholar 

  85. Schweikert HU, Wilson JD (1974) Regulation of human hair growth by steroid hormones. I. Testosterone metabolism in isolated hairs. J Clin Endocrinol Metab 38: 811-819

    Article  PubMed  CAS  Google Scholar 

  86. Sciarra F, Toscano V, Concolino G, et al (1990) Anti-androgens: clinical applications. J Steroid Biochem Mol Biol; 37: 349-362

    Article  PubMed  CAS  Google Scholar 

  87. Shum KW, Cullen DR, Messenger AG (2002) Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol; 47: 733-739

    Article  PubMed  Google Scholar 

  88. Sinclair R (2004) The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women. J Am Acad Dermatol; 51: 189-199

    Article  PubMed  Google Scholar 

  89. Sinclair R, Wewerinke M, Jolley D (2005) Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol; 152: 466-473

    Article  PubMed  CAS  Google Scholar 

  90. Smith IE, Dowsett M (2003) Aromatase inhibitors in breast cancer. N Engl J Med; 348: 2431-2442

    Article  PubMed  CAS  Google Scholar 

  91. Smith MA, Wells RS (1964) Male-type alopecia, alopecia areata and normal hair in women: family histories. Arch Dermatol; 89: 95-98

    Article  PubMed  CAS  Google Scholar 

  92. Thai K-E, Sinclair RD (2002) Finasteride for female androgenetic alopecia. Br J Dermatol; 147: 808-840

    Article  Google Scholar 

  93. Thornton MJ (2002) The biological actions of estrogens on skin. Exp Dermatol; 11: 487-502

    Article  PubMed  CAS  Google Scholar 

  94. Tindll DJ, Chang CH, Lobl TJ, et al (1984) Androgen antagonists in androgen target tissues. Pharmacol Ther; 24: 367-400

    Article  Google Scholar 

  95. Tremblay RR (1986) Treatment of hirsutism with spironolactone. Clin Endocrinol Metab; 15: 363-371

    Article  PubMed  CAS  Google Scholar 

  96. Trost LB, Bergfeld WF, Calgeras E (2006) The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol; 54: 824-844

    Article  PubMed  Google Scholar 

  97. Trueb RM (2004) Finasteride treatment of patterned hair loss in normoandrogenic postmenopausal women. Dermatology; 209: 202-207

    Article  PubMed  CAS  Google Scholar 

  98. Ueki R, Tsuboi R, Inaba Y, et al (2003) Phototrichogram analysis of Japanese female subjects with chronic diffuse hair loss. J Investig Dermatol Symp Proc; 8: 116-120

    Article  PubMed  Google Scholar 

  99. Unger WP, Hair transplantation in females. In: Unger WP (ed) (1988) Hair Transplantation. Dekker, New York, pp. 295-300

    Google Scholar 

  100. Unger WP, Unger RH (2003) Hair transplanting: an important but often forgotten treatment for female pattern hair loss. J Am Acad Dermatol; 49: 853-860

    Article  PubMed  Google Scholar 

  101. Uno H, Cappas A, Schlagel C (1985) Cyclic dynamics of hair follicles and the effect of minoxidil on the bald scalps of stumptailed macaques. Am J Dermatopathol; 7: 283-297

    Article  PubMed  CAS  Google Scholar 

  102. Valsecchi R, Leghissa P, Riva M (2004) Female androgenetic alopecia treated by finasteride: a case forward. Acta Derm Venereol; 84: 488-489

    Article  PubMed  Google Scholar 

  103. Vanwayjen RG, Van den Ende A (1995) Experience in the long term treatment of patients with hirsutism and/or acne with cyproterone acetate containing preparations: efficacy, metabolic and endocrine effects. Exp Clin Endocrinol Diabetes; 103: 241-251

    Article  CAS  Google Scholar 

  104. Venning VA, Dawber RPR (1988) Patterned androgenic alopecia in women. J Am Acad Dermatol; 18: 1073-1077

    Article  PubMed  CAS  Google Scholar 

  105. Vexiau P, Chaspoux C, Boudou P, et al (2002) Effects of minoxidil 2% vs cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial. Br J Dermatol; 146: 992-999

    Article  PubMed  CAS  Google Scholar 

  106. Vierhapper H, Nowotny P, Maier H, et al (2001) Production rates of dihydrotestosterone in healthy men and women and in men with male pattern baldness: determination by stable isotope/dilution and mass spectrometry. J Clin Endocrinol Metab; 86: 5752-5764

    Article  Google Scholar 

  107. Vierhapper H, Maier H, Nowotny P, et al (2003) Production rates of testosterone and dihydrotestosterone in female pattern hair loss. Metabolism; 52: 927-929

    Article  PubMed  CAS  Google Scholar 

  108. Whiting DA (1993) The diagnostic and predictive value of horizontal sections of scalp biopsies in male pattern androgenetic alopecia. J Am Acad Dermatol; 28: 755-763

    Article  PubMed  CAS  Google Scholar 

  109. Whiting DA (1996) Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol; 35: 899-906

    Article  PubMed  CAS  Google Scholar 

  110. Whiting DA (1998) Scalp biopsy as a diagnostic and prognostic tool in androgenetic alopecia. Dermatol Ther; 8: 24-33

    Google Scholar 

  111. Whiting DA, Waldstreicher J, Sanchez M, et al (1999) Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies. Results of finasteride 1 mg treatment of men and postmenopausal women. J Invest Dermatol Symp Proc; 4: 282-284

    Article  CAS  Google Scholar 

  112. Yasmin (2007) Physician’s Desk reference; 61: 796-803

    Google Scholar 

  113. Zajac JD (2003) Women, androgens and skin (abstract). Exp Dermatol; 12: 224

    Article  Google Scholar 

  114. Zinkernagel MS, Trueb RN (2002) Fibrosing alopecia in a pattern distribution: patterned lichen planopilaris or androgenetic alopecia with a lichenoid tissue reaction pattern? Arch Dermatol; 135: 205-211

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division Dermatology and Oncology, Duke University Medical Center, Box 3294 DUMC, 27710, Durham, NC, USA

    Elise A. Olsen

Authors
  1. Elise A. Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Research Center for Hair and Skin Physiology (CRC), Charité -Universitätsmedizin Berlin, Charitéplatz 1, 11017 , Berlin, Germany

    Ulrike Blume-Peytavi

  2. Department of Dermatology, University of Bologna, Via Massarenti, 1, 40138 , Bologna, Italy

    Antonella Tosti

  3. Department of Dermatology, University Hospital of Zürich, Gloriastrasse 31, 8091 , Zürich, Switzerland

    Ralph M. Trüeb

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer London

About this chapter

Cite this chapter

Olsen, E. (2008). Female Pattern Hair Loss. In: Blume-Peytavi, U., Tosti, A., Trüeb, R. (eds) Hair Growth and Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-46911-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-46911-7_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-46908-7

  • Online ISBN: 978-3-540-46911-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation